thyroxine has been researched along with Arrhythmias, Cardiac in 85 studies
Thyroxine: The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism.
thyroxine : An iodothyronine compound having iodo substituents at the 3-, 3'-, 5- and 5'-positions.
Arrhythmias, Cardiac: Any disturbances of the normal rhythmic beating of the heart or MYOCARDIAL CONTRACTION. Cardiac arrhythmias can be classified by the abnormalities in HEART RATE, disorders of electrical impulse generation, or impulse conduction.
Excerpt | Relevance | Reference |
---|---|---|
"Background Amiodarone is an iodine-rich medication used to treat maternal and fetal arrhythmias, with known effects on thyroid hormone homeostasis." | 7.91 | Transient neonatal hypothyroidism following a short course of maternal amiodarone therapy. ( Huang, V; Wolf, RM, 2019) |
"Minimally invasive video-assisted thyroidectomy under regional anesthesia can be proposed as resolution of amiodarone-induced thyrotoxicosis in high risk patients with severe cardiac disorders, after preparation with iopanoic acid." | 7.74 | Combination of minimally invasive thyroid surgery and local anesthesia associated to iopanoic acid for patients with amiodarone-induced thyrotoxicosis and severe cardiac disorders: a pilot study. ( Ambrosini, CE; Berti, P; Bogazzi, F; Martino, E; Materazzi, G; Miccoli, P, 2007) |
"Amiodarone-induced thyrotoxicosis (AIT) is a challenging management problem, since patients treated with amiodarone invariably have underlying heart disease." | 7.73 | Amiodarone-induced thyrotoxicosis: left ventricular dysfunction is associated with increased mortality. ( Diamond, T; Lewis, M; O'Sullivan, AJ, 2006) |
"Amiodarone-induced thyrotoxicosis (AIT) may develop either in apparently normal thyroid glands (Type II AIT) or in the presence of sub-clinical thyroid abnormalities (either autonomous goiter or latent Graves' disease; Type I AIT)." | 7.71 | Iopanoic acid rapidly controls type I amiodarone-induced thyrotoxicosis prior to thyroidectomy. ( Aghini-Lombardi, F; Bartalena, L; Basolo, F; Bogazzi, F; Braverman, LE; Cosci, C; Lupi, I; Martino, E; Miccoli, P; Pinchera, A; Santini, F; Tanda, ML, 2002) |
"Amiodarone-induced thyrotoxicosis (AIT) is a difficult management problem about which there are little published data." | 7.71 | Successful treatment of amiodarone-induced thyrotoxicosis. ( Franklyn, JA; Gammage, MD; Osman, F; Sheppard, MC, 2002) |
"Because little has been published on early effects of treatment with amiodarone on thyroid function, we studied serum total and free thyroid hormone, reverse T3, and TSH levels in patients with cardiac arrhythmias during the first 10 days of treatment with a loading dose of amiodarone by iv infusion." | 7.69 | Acute effects of amiodarone administration on thyroid function in patients with cardiac arrhythmia. ( Berti, S; Biagini, A; Bonini, R; Carpi, A; Chopra, IJ; Clerico, A; Iervasi, G; Manfredi, C; Palmieri, C; Ravani, M, 1997) |
"Levothyroxine-induced heart hypertrophy is a suitable model for severe ischemia and arrhythmias in rats." | 7.69 | Heart hypertrophy induced by levothyroxine aggravates ischemic lesions and reperfusion arrhythmias in rats. ( An, LF; Dai, DZ; Guo, XF; Yu, F, 1997) |
"Amiodarone treatment in pregnancy might be difficult to handle because of the long half-life of the drug (14-28 days up to 2 months) and because it reduces maternal and neonatal thyroid activity." | 7.68 | Amiodarone treatment in pregnancy for dilatative cardiomyopathy with ventricular malignant extrasystole and normal maternal and neonatal outcome. ( Civitella, C; Garzetti, GG; Romanini, C; Valensise, H, 1992) |
"Out of 20 subjects selected for refractory arrhythmias, amiodarone therapy (200 mg/day) was efficacious in 85%." | 7.67 | Amiodarone and thyroid status in refractory arrhythmias. ( Codecà, L; Colamussi, V; Giganti, M; Giovannini, G; Pelizzola, D; Piffanelli, A; Ricci, L, 1988) |
" Since myocardial calcium uptake is increased in thyrotoxic rats, the efficacy of the calcium channel-blocking drug diltiazem in decreasing heart rate and the incidence of arrhythmias was evaluated in 11 hyperthyroid patients." | 7.67 | The effect of diltiazem, a calcium channel-blocking drug, on cardiac rate and rhythm in hyperthyroid patients. ( Bentivoglio, M; Braverman, LE; Gardini, E; Guiducci, U; Minelli, R; Montermini, M; Robuschi, G; Roti, E; Roti, S; Salvi, M, 1988) |
"Cardiac arrhythmias and the deterioration of osteoporosis are the most frequently documented side-effects of LT4 therapy." | 6.72 | Levothyroxine Treatment and the Risk of Cardiac Arrhythmias - Focus on the Patient Submitted to Thyroid Surgery. ( Essack, M; Gluvic, Z; Gojobori, T; Isenovic, ER; Obradovic, M; Pitt, SJ; Samardzic, V; Soskic, S; Stewart, AJ, 2021) |
"Examining the course of cardiac arrhythmias (CA) in developed TT has established that this condition gives rise to their recurrence." | 5.32 | [The specific features of thyrotoxicosis and euthyroid hyperthyroxinemia developed due to the use of cordarone]. ( Bakalov, SA; Domogadskiĭ, SP; Golitsyn, SP; Kolesnikova, GS; Masenko, VP; Molashenko, NV; Platonova, NM; Serdiuk, SE; Sviridenko, NIu, 2004) |
"Amiodarone is a widely used antiarrhythmic drug, which contains 75 mg of iodide per 200 mg of active substance." | 5.27 | Amiodarone-induced hypothyroidism. A common complication of prolonged therapy: a report of eight cases. ( Atkinson, AB; Campbell, NP; Ferguson, WR; Geddes, JS; Hawthorne, GC; Postlethwaite, W; Sheridan, B, 1985) |
"Amiodarone has a good antiarrhythmic effect administered either acutely or chronically." | 5.27 | [Acute antiarrhythmia treatment with amiodarone and blood levels of thyroid hormones]. ( Fazzini, PF; Gheri, RG; Marchi, F; Multinu, D; Paladini, S; Zambaldi, G, 1987) |
"Amiodarone hydrochloride is a relatively new antiarrhythmic agent, the properties of which differ in a significant manner electrophysiologically, pharmacokinetically and structurally from those of conventional as well as other investigational antidysrhythmic compounds." | 5.27 | The clinical results of amiodarone in cardiac arrhythmias: optimal dosing. ( Ikeda, N; Kannan, R; Nademanee, K; Singh, BN, 1984) |
"Hyperthyroidism was diagnosed in the 18 patients (21%) with negative TRH test; 15 of them had high free thyroxine (FT4) levels." | 5.27 | [Fruste form of hyperthyroidism manifested by auricular arrhythmia. Importance of the assay of the free fraction of thyroxine (FT4) and the role of the TRH test]. ( Bigorgne, JC; Galland, F; Getin, F; Hocq, R; Jallet, P; Rohmer, V; Tadei, A, 1984) |
"Subclinical hyperthyroidism is defined by a subnormal serum thyroidstimulating hormone (TSH) level with normal free thyroxine (FT4) and free triiodothyronine (FT3) levels." | 3.96 | Role of Subclinical Iatrogenic Hyperthyroidism in the Setting of Heart Disease and Arrhythmic Burden. ( De Luca, G; Di Stolfo, G; Maggio, A; Massaro, R; Mastroianno, S; Pacilli, M; Potenza, DR; Russo, A, 2020) |
" The aim of this study was to show how the Tpeak -Tend (Tpe) interval, which is a new marker of ventricular arrythmia, is affected in patients who have become euthyroid following Levothyroxine treatment for hypothyroidism, as this has not been examined previously in literature." | 3.91 | The relationship between the TSH values and the Tpeak - Tend interval duration in hypothyroid patients receiving Levothyroxine treatment. ( Aydin, H; Findikli, HA; Tutak, AŞ, 2019) |
"Background Amiodarone is an iodine-rich medication used to treat maternal and fetal arrhythmias, with known effects on thyroid hormone homeostasis." | 3.91 | Transient neonatal hypothyroidism following a short course of maternal amiodarone therapy. ( Huang, V; Wolf, RM, 2019) |
"Amiodarone is used for the maintenance of sinus rhythm in patients with arrhythmias, but thyroid dysfunction (amiodarone-induced thyrotoxicosis (AIT) or amiodarone-induced hypothyroidism (AIH)) is a common adverse effect." | 3.85 | The clinical value of regular thyroid function tests during amiodarone treatment. ( Benjamens, S; Dullaart, RPF; Links, TP; Rienstra, M; Sluiter, WJ; van Gelder, IC, 2017) |
" We assessed the subjects according to the Simplified Menopause Index, menstrual status, thyroid hormone measurements (thyroid stimulating hormone, free thyroxine, free triiodothyronine), the presence of Hashimoto's disease antibodies (anti-thyroid peroxidase antibody or anti-thyroglobulin antibody), the presence of Grave's disease (anti-TSH receptor antibody), markers of thyroid tumor (high thyroglobulin), and thyroid ultrasonography studies." | 3.79 | Comparison of the symptoms of menopause and symptoms of thyroid disease in Japanese women aged 35-59 years. ( Ohi, K; Oi, N, 2013) |
"Minimally invasive video-assisted thyroidectomy under regional anesthesia can be proposed as resolution of amiodarone-induced thyrotoxicosis in high risk patients with severe cardiac disorders, after preparation with iopanoic acid." | 3.74 | Combination of minimally invasive thyroid surgery and local anesthesia associated to iopanoic acid for patients with amiodarone-induced thyrotoxicosis and severe cardiac disorders: a pilot study. ( Ambrosini, CE; Berti, P; Bogazzi, F; Martino, E; Materazzi, G; Miccoli, P, 2007) |
"Amiodarone-induced thyrotoxicosis (AIT) is a challenging management problem, since patients treated with amiodarone invariably have underlying heart disease." | 3.73 | Amiodarone-induced thyrotoxicosis: left ventricular dysfunction is associated with increased mortality. ( Diamond, T; Lewis, M; O'Sullivan, AJ, 2006) |
"Amiodarone-induced thyrotoxicosis developed in 31 patients (49." | 3.72 | Amiodarone-induced thyroid dysfunction in cardiac patients from areas with iodine deficiency. ( Barbu, C; Bunghez, R; Coculescu, M; Fica, S; Trifănescu, R; Ursu, H; Vârtej, I, 2004) |
"Amiodarone-induced thyrotoxicosis (AIT) may develop either in apparently normal thyroid glands (Type II AIT) or in the presence of sub-clinical thyroid abnormalities (either autonomous goiter or latent Graves' disease; Type I AIT)." | 3.71 | Iopanoic acid rapidly controls type I amiodarone-induced thyrotoxicosis prior to thyroidectomy. ( Aghini-Lombardi, F; Bartalena, L; Basolo, F; Bogazzi, F; Braverman, LE; Cosci, C; Lupi, I; Martino, E; Miccoli, P; Pinchera, A; Santini, F; Tanda, ML, 2002) |
"Amiodarone-induced thyrotoxicosis (AIT) is a difficult management problem about which there are little published data." | 3.71 | Successful treatment of amiodarone-induced thyrotoxicosis. ( Franklyn, JA; Gammage, MD; Osman, F; Sheppard, MC, 2002) |
"Because little has been published on early effects of treatment with amiodarone on thyroid function, we studied serum total and free thyroid hormone, reverse T3, and TSH levels in patients with cardiac arrhythmias during the first 10 days of treatment with a loading dose of amiodarone by iv infusion." | 3.69 | Acute effects of amiodarone administration on thyroid function in patients with cardiac arrhythmia. ( Berti, S; Biagini, A; Bonini, R; Carpi, A; Chopra, IJ; Clerico, A; Iervasi, G; Manfredi, C; Palmieri, C; Ravani, M, 1997) |
"Levothyroxine-induced heart hypertrophy is a suitable model for severe ischemia and arrhythmias in rats." | 3.69 | Heart hypertrophy induced by levothyroxine aggravates ischemic lesions and reperfusion arrhythmias in rats. ( An, LF; Dai, DZ; Guo, XF; Yu, F, 1997) |
"The pharmacological effects of the toad venom-containing drug "kyushin" on aconitine- and thyroxine-induced arrhythmia in guinea pigs, on the conduction system in Langendorff preparations of rabbit hearts and on the autonomic nervous system in cats were studied." | 3.68 | Pharmacological actions of "kyushin," a drug containing toad venom (3): Effects on experimentally induced arrhythmia. ( Higuchi, M; Hirai, Y; Ito, C; Morishita, S; Oguni, Y; Sakanashi, M; Shoji, M; Sugimoto, C, 1993) |
"Amiodarone treatment in pregnancy might be difficult to handle because of the long half-life of the drug (14-28 days up to 2 months) and because it reduces maternal and neonatal thyroid activity." | 3.68 | Amiodarone treatment in pregnancy for dilatative cardiomyopathy with ventricular malignant extrasystole and normal maternal and neonatal outcome. ( Civitella, C; Garzetti, GG; Romanini, C; Valensise, H, 1992) |
" Since myocardial calcium uptake is increased in thyrotoxic rats, the efficacy of the calcium channel-blocking drug diltiazem in decreasing heart rate and the incidence of arrhythmias was evaluated in 11 hyperthyroid patients." | 3.67 | The effect of diltiazem, a calcium channel-blocking drug, on cardiac rate and rhythm in hyperthyroid patients. ( Bentivoglio, M; Braverman, LE; Gardini, E; Guiducci, U; Minelli, R; Montermini, M; Robuschi, G; Roti, E; Roti, S; Salvi, M, 1988) |
" Only 6 of the 14 patients with hyperthyroxinaemia had TSH-U values in the hyperthyroid range: only one of these patients had an increased triiodothyronine." | 3.67 | [Ultra-sensitive TSH levels: an aid in the screening for amiodarone-induced thyroid dysfunction]. ( Chabrier, G; Dickelé, MC; Fellinger, F; Gasser, F; Roul, G; Sacrez, A; Sapin, R; Schlienger, JL, 1986) |
"Out of 20 subjects selected for refractory arrhythmias, amiodarone therapy (200 mg/day) was efficacious in 85%." | 3.67 | Amiodarone and thyroid status in refractory arrhythmias. ( Codecà, L; Colamussi, V; Giganti, M; Giovannini, G; Pelizzola, D; Piffanelli, A; Ricci, L, 1988) |
" There were no differences in age, sex, dose of amiodarone, type or severity of underlying heart disease or baseline serum thyroxine levels in patients who developed hypothyroidism (n = 32) or hyperthyroidism (n = 5) or remained euthyroid (n = 62)." | 3.67 | Thyroid dysfunction during chronic amiodarone therapy. ( Albert, SG; Alves, LE; Rose, EP, 1987) |
"Therapeutic use of the potent antiarrhythmic drug amiodarone requires early detection of impending hyperthyroidism, a potentially life-threatening adverse reaction in cardiac patients." | 3.67 | Amiodarone-treated patients with suppressed TSH test are at risk of thyrotoxicosis. ( Stäubli, M; Studer, H, 1985) |
"Both hyperthyroidism and hypothyroidism have been noted to occur in some patients treated with amiodarone for cardiac arrhythmias." | 3.67 | Effect of long-term amiodarone therapy on thyroid hormone levels and thyroid function. ( Borowski, GD; Garofano, CD; Greenspan, AM; Horowitz, LN; Rose, LI; Rotmensch, HR; Spielman, SR, 1985) |
"Amiodarone, an iodinated benzofuran derivative, has electrophysiologic effects on cardiac muscle akin to those of hypothyroidism." | 3.66 | Amiodarone and thyroid function: clinical implications during antiarrhythmic therapy. ( Nademanee, K; Singh, BN, 1983) |
"Cardiac arrhythmias and the deterioration of osteoporosis are the most frequently documented side-effects of LT4 therapy." | 2.72 | Levothyroxine Treatment and the Risk of Cardiac Arrhythmias - Focus on the Patient Submitted to Thyroid Surgery. ( Essack, M; Gluvic, Z; Gojobori, T; Isenovic, ER; Obradovic, M; Pitt, SJ; Samardzic, V; Soskic, S; Stewart, AJ, 2021) |
"60 patients with CVMC complicated with arrhythmia were continuously selected (course of disease > 3 months) and they are were diagnosed with arrhythmia by the routine 18-lead electrocardiogram and 24-hour Holter; the average follow-up time is about 2 years, during which the left ventricular end-diastolic diameter (LVEDd), left ventricular ejection fraction (LVEF), the occurrence rate of malignant arrhythmia events, immune state of T cell and thyroid hormone level (FT3, FT4, TSH, TGAb and TPOAb) were compared." | 1.46 | Relevant researches on chronic viral myocarditis (CVMC) in children, complicated with arrhythmia and thyroid hormone level. ( An, XJ; Fu, MY; Li, CL; Wang, QW; Xu, F; Xue, Y, 2017) |
"Cardiac arrhythmias as well as atrial fibrillation were similarly detected by conventional and non-conventional approaches (chi-square test: P = 0." | 1.43 | Early detection of biochemically occult autonomous thyroid nodules. ( Brusca, N; Capriello, S; Cellini, M; Centanni, M; Gargano, L; Salvatori, R; Santaguida, MG; Virili, C, 2016) |
"Fetal tachyarrhythmias complicate 0." | 1.42 | Fetuses of Mothers with Thyroid Disease May Be at Higher Risk of Developing Supraventricular Tachycardia. ( Fish, FA; Johnson, JA; Kavanaugh-McHugh, A; Killen, SA; Lu, Z; Williams, P, 2015) |
"Examining the course of cardiac arrhythmias (CA) in developed TT has established that this condition gives rise to their recurrence." | 1.32 | [The specific features of thyrotoxicosis and euthyroid hyperthyroxinemia developed due to the use of cordarone]. ( Bakalov, SA; Domogadskiĭ, SP; Golitsyn, SP; Kolesnikova, GS; Masenko, VP; Molashenko, NV; Platonova, NM; Serdiuk, SE; Sviridenko, NIu, 2004) |
"Subclinical hyperthyroidism has been associated with harmful cardiac effects, but its treatment remains controversial." | 1.32 | The effects of early antithyroid therapy for endogenous subclinical hyperthyroidism in clinical and heart abnormalities. ( Garbeline, B; Romaldini, JH; Sgarbi, JA; Villaça, FG; Villar, HE, 2003) |
"Amiodarone was administered by i." | 1.30 | Acute effects of intravenous amiodarone on sulphate metabolites of thyroid hormones in arrhythmic patients. ( Biagini, A; Chopra, IJ; Clerico, A; Iervasi, G; Manfredi, C; Sabatino, L, 1997) |
"Hyperthyroidism was diagnosed in the 18 patients (21%) with negative TRH test; 15 of them had high free thyroxine (FT4) levels." | 1.27 | [Fruste form of hyperthyroidism manifested by auricular arrhythmia. Importance of the assay of the free fraction of thyroxine (FT4) and the role of the TRH test]. ( Bigorgne, JC; Galland, F; Getin, F; Hocq, R; Jallet, P; Rohmer, V; Tadei, A, 1984) |
"Hypothyroidism was diagnosed in 11 patients (12%), and a further 11 had tests consistent with a "failing thyroid." | 1.27 | Effect of amiodarone on thyroid hormone economy. ( Glick, S; Posner, J; Sobel, RJ, 1984) |
"Amiodarone hydrochloride is a relatively new antiarrhythmic agent, the properties of which differ in a significant manner electrophysiologically, pharmacokinetically and structurally from those of conventional as well as other investigational antidysrhythmic compounds." | 1.27 | The clinical results of amiodarone in cardiac arrhythmias: optimal dosing. ( Ikeda, N; Kannan, R; Nademanee, K; Singh, BN, 1984) |
"Amiodarone has a good antiarrhythmic effect administered either acutely or chronically." | 1.27 | [Acute antiarrhythmia treatment with amiodarone and blood levels of thyroid hormones]. ( Fazzini, PF; Gheri, RG; Marchi, F; Multinu, D; Paladini, S; Zambaldi, G, 1987) |
"Amiodarone is a widely used antiarrhythmic drug, which contains 75 mg of iodide per 200 mg of active substance." | 1.27 | Amiodarone-induced hypothyroidism. A common complication of prolonged therapy: a report of eight cases. ( Atkinson, AB; Campbell, NP; Ferguson, WR; Geddes, JS; Hawthorne, GC; Postlethwaite, W; Sheridan, B, 1985) |
"Bradyarrhythmias are sometimes observed in hypothyroid patients." | 1.27 | Long-term ECG recordings in thyroxine-substituted hypothyroid subjects. ( Edhag, O; Hylander, B; Kennebäck, G; Rosenqvist, U, 1987) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 42 (49.41) | 18.7374 |
1990's | 11 (12.94) | 18.2507 |
2000's | 17 (20.00) | 29.6817 |
2010's | 12 (14.12) | 24.3611 |
2020's | 3 (3.53) | 2.80 |
Authors | Studies |
---|---|
Gluvic, Z | 1 |
Obradovic, M | 1 |
Stewart, AJ | 1 |
Essack, M | 1 |
Pitt, SJ | 1 |
Samardzic, V | 1 |
Soskic, S | 1 |
Gojobori, T | 1 |
Isenovic, ER | 1 |
Sari, A | 1 |
Dural, IE | 1 |
Aksu, U | 1 |
Korucu, C | 1 |
Bozkurt, E | 1 |
Apaydin, M | 1 |
Mastroianno, S | 1 |
Di Stolfo, G | 1 |
Maggio, A | 1 |
Pacilli, M | 1 |
Potenza, DR | 1 |
Massaro, R | 1 |
De Luca, G | 1 |
Russo, A | 1 |
Benjamens, S | 1 |
Dullaart, RPF | 1 |
Sluiter, WJ | 1 |
Rienstra, M | 1 |
van Gelder, IC | 1 |
Links, TP | 1 |
Fu, MY | 1 |
Wang, QW | 1 |
Xue, Y | 1 |
Xu, F | 1 |
Li, CL | 1 |
An, XJ | 1 |
Zhang, K | 1 |
Tang, YD | 1 |
Zhang, Y | 1 |
Ojamaa, K | 2 |
Li, Y | 1 |
Saini, AS | 1 |
Carrillo-Sepulveda, MA | 1 |
Rajagopalan, V | 1 |
Gerdes, AM | 1 |
Findikli, HA | 1 |
Tutak, AŞ | 1 |
Aydin, H | 1 |
Huang, V | 1 |
Wolf, RM | 1 |
Blake, RR | 1 |
Longo, M | 1 |
Santarelli, G | 1 |
Liuti, T | 1 |
Martinez-Pereira LdaVet, Y | 1 |
Krysicki, M | 1 |
Slusarczyk, E | 1 |
Popowicz, B | 1 |
Jankiewicz-Wika, J | 1 |
Klencki, M | 1 |
Słowińska-Klencka, D | 1 |
Johnson, JA | 1 |
Williams, P | 1 |
Lu, Z | 1 |
Kavanaugh-McHugh, A | 1 |
Fish, FA | 1 |
Killen, SA | 1 |
Brusca, N | 1 |
Virili, C | 1 |
Cellini, M | 1 |
Capriello, S | 1 |
Gargano, L | 1 |
Salvatori, R | 1 |
Centanni, M | 1 |
Santaguida, MG | 1 |
Flores-González, JC | 1 |
Grujic, B | 1 |
Lechuga-Sancho, AM | 1 |
Brent, GA | 1 |
Makusheva, MV | 1 |
Kileĭnikov, DV | 1 |
Talukder, MA | 1 |
Yang, F | 1 |
Nishijima, Y | 1 |
Chen, CA | 1 |
Xie, L | 1 |
Mahamud, SD | 1 |
Kalyanasundaram, A | 1 |
Bonagura, JD | 1 |
Periasamy, M | 1 |
Zweier, JL | 1 |
Oi, N | 1 |
Ohi, K | 1 |
Sgarbi, JA | 1 |
Villaça, FG | 1 |
Garbeline, B | 1 |
Villar, HE | 1 |
Romaldini, JH | 1 |
LIPTON, EL | 1 |
VOORHESS, ML | 1 |
STEINSCHNEIDER, A | 1 |
HOLLOWELL, J | 1 |
COX, PJ | 1 |
GARDNER, LI | 1 |
Sych, IuP | 1 |
Kalatnikov, VIu | 1 |
Syrkin, AL | 1 |
Mel'nichenko, GA | 1 |
Telkova, IL | 1 |
Karpov, RS | 1 |
Molashenko, NV | 1 |
Sviridenko, NIu | 1 |
Platonova, NM | 1 |
Kolesnikova, GS | 1 |
Golitsyn, SP | 1 |
Bakalov, SA | 1 |
Serdiuk, SE | 1 |
Masenko, VP | 1 |
Domogadskiĭ, SP | 1 |
Yamakawa, M | 1 |
Sunagawa, M | 1 |
Shimabukuro, M | 1 |
Higa, N | 1 |
Takasu, N | 1 |
Kosugi, T | 1 |
Trifănescu, R | 1 |
Fica, S | 1 |
Barbu, C | 1 |
Vârtej, I | 1 |
Ursu, H | 1 |
Bunghez, R | 1 |
Coculescu, M | 1 |
Owecki, M | 2 |
Michalak, A | 2 |
Nikisch, E | 2 |
Sowiński, J | 2 |
O'Sullivan, AJ | 1 |
Lewis, M | 1 |
Diamond, T | 1 |
Berti, P | 1 |
Materazzi, G | 1 |
Bogazzi, F | 2 |
Ambrosini, CE | 1 |
Martino, E | 2 |
Miccoli, P | 2 |
Samuels, MA | 1 |
Fredlund, BO | 1 |
Olsson, SB | 1 |
Singh, BN | 5 |
Nademanee, K | 4 |
Kannan, R | 1 |
Ikeda, N | 1 |
Rohmer, V | 1 |
Hocq, R | 1 |
Galland, F | 1 |
Getin, F | 1 |
Tadei, A | 1 |
Jallet, P | 1 |
Bigorgne, JC | 1 |
McKenna, WJ | 1 |
Rowland, E | 1 |
Krikler, DM | 1 |
Posner, J | 1 |
Sobel, RJ | 1 |
Glick, S | 1 |
Davis, PJ | 1 |
Davis, FB | 1 |
de los Angeles Valenzuela, M | 1 |
Bianchi, C | 2 |
Meruane, J | 1 |
Pineda, G | 1 |
Livshits, GIa | 1 |
Rod, JL | 1 |
Shenasa, M | 1 |
Dunn, JT | 1 |
Melmed, S | 1 |
Reed, AW | 1 |
Hendrickson, JA | 1 |
Hershman, JM | 2 |
Stäubli, M | 2 |
Bischof, P | 1 |
Wimpfheimer, C | 1 |
Studer, H | 2 |
Smith, CD | 1 |
Ain, KB | 1 |
Ryan, S | 1 |
Ngai, BC | 1 |
Biondi, B | 2 |
Fazio, S | 2 |
Carella, C | 2 |
Sabatini, D | 1 |
Amato, G | 2 |
Cittadini, A | 2 |
Bellastella, A | 2 |
Lombardi, G | 2 |
Saccà, L | 2 |
Morishita, S | 1 |
Sugimoto, C | 1 |
Shoji, M | 1 |
Hirai, Y | 1 |
Oguni, Y | 1 |
Ito, C | 1 |
Higuchi, M | 1 |
Sakanashi, M | 1 |
Lupoli, G | 1 |
Iervasi, G | 2 |
Clerico, A | 2 |
Bonini, R | 1 |
Manfredi, C | 2 |
Berti, S | 1 |
Ravani, M | 1 |
Palmieri, C | 1 |
Carpi, A | 1 |
Biagini, A | 2 |
Chopra, IJ | 2 |
Sabatino, L | 1 |
Yu, F | 1 |
Dai, DZ | 2 |
An, LF | 1 |
Guo, XF | 1 |
Hu, HJ | 1 |
Yang, DM | 1 |
Hao, XM | 1 |
Zhang, GQ | 1 |
Zhou, PA | 1 |
Wu, CH | 1 |
Klein, I | 1 |
Vesely, DL | 1 |
Osman, F | 1 |
Franklyn, JA | 2 |
Sheppard, MC | 2 |
Gammage, MD | 2 |
Aghini-Lombardi, F | 1 |
Cosci, C | 1 |
Lupi, I | 1 |
Santini, F | 1 |
Tanda, ML | 1 |
Basolo, F | 1 |
Pinchera, A | 1 |
Bartalena, L | 1 |
Braverman, LE | 2 |
Piffanelli, A | 2 |
Pelizzola, D | 2 |
Ricci, L | 2 |
Codecá, L | 2 |
Masoni, A | 1 |
Romelli, PB | 1 |
Symons, C | 1 |
Myers, A | 1 |
Kingstone, D | 1 |
Boss, M | 1 |
Rösler, H | 1 |
Jenni, C | 1 |
Noelpp, U | 1 |
Kinser, J | 1 |
Heyma, P | 1 |
Larkins, RG | 1 |
Perry-Keene, D | 1 |
Peter, CT | 1 |
Ross, D | 1 |
Sloman, JG | 1 |
Lüderitz, B | 1 |
Valensise, H | 1 |
Civitella, C | 1 |
Garzetti, GG | 1 |
Romanini, C | 1 |
Gasińska, T | 1 |
Mandecki, T | 1 |
Szydło, E | 1 |
Szulc, A | 1 |
Nowakowska, M | 1 |
Venkatesh, N | 1 |
Lynch, JJ | 1 |
Uprichard, AC | 1 |
Kitzen, JM | 1 |
Lucchesi, BR | 1 |
Gheri, RG | 1 |
Marchi, F | 1 |
Zambaldi, G | 1 |
Multinu, D | 1 |
Paladini, S | 1 |
Fazzini, PF | 1 |
Roti, E | 1 |
Montermini, M | 1 |
Roti, S | 1 |
Gardini, E | 1 |
Robuschi, G | 1 |
Minelli, R | 1 |
Salvi, M | 1 |
Bentivoglio, M | 1 |
Guiducci, U | 1 |
Bozhko, AP | 1 |
Sukhorukova, TA | 1 |
Hawthorne, GC | 1 |
Campbell, NP | 1 |
Geddes, JS | 1 |
Ferguson, WR | 1 |
Postlethwaite, W | 1 |
Sheridan, B | 1 |
Atkinson, AB | 1 |
Schlienger, JL | 1 |
Dickelé, MC | 1 |
Roul, G | 1 |
Sapin, R | 1 |
Chabrier, G | 1 |
Gasser, F | 1 |
Fellinger, F | 1 |
Sacrez, A | 1 |
Giovannini, G | 1 |
Giganti, M | 1 |
Colamussi, V | 1 |
Hylander, B | 1 |
Kennebäck, G | 1 |
Rosenqvist, U | 1 |
Edhag, O | 1 |
Barańska, H | 1 |
Frank-Piskorska, A | 1 |
Konieczna, M | 1 |
Albert, SG | 1 |
Alves, LE | 1 |
Rose, EP | 1 |
Donaghue, KC | 1 |
Clarke, P | 1 |
Hooper, MJ | 1 |
Sugawara, M | 1 |
Pekary, AE | 1 |
Ross, R | 1 |
DiStefano, JJ | 1 |
Meese, R | 1 |
Smitherman, TC | 1 |
Croft, CH | 1 |
Burger, A | 1 |
Nicod, P | 1 |
Borowski, GD | 1 |
Garofano, CD | 1 |
Rose, LI | 1 |
Spielman, SR | 1 |
Rotmensch, HR | 1 |
Greenspan, AM | 1 |
Horowitz, LN | 1 |
Davis, JR | 1 |
Littler, WA | 1 |
Ramsden, DB | 1 |
Zhou, YF | 1 |
Huang, DX | 1 |
Li, ZJ | 1 |
Van Heerden, BB | 1 |
Klopper, JF | 1 |
Weich, HF | 1 |
Van Heerden, PD | 1 |
Herrmann, J | 1 |
Hilger, P | 1 |
Rusche, HJ | 1 |
Krüskemper, HL | 1 |
el-Khodary, AZ | 1 |
Thiffault, C | 1 |
Deschenes, L | 1 |
Couture, J | 1 |
Thompson, EB | 1 |
Perelman, R | 1 |
de Gennes, JL | 1 |
Devaux, JP | 1 |
Pouliot, P | 1 |
Marie, J | 1 |
Kattus, AA | 1 |
Biscoe, BW | 1 |
Dashe, AM | 1 |
Davis, JH | 1 |
Sanna, GP | 1 |
Turba, C | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Effect of Levothyroxine on Serum Adiponectin, Insulin Resistance and Cardiovascular Risk in Patients With Hypothyroidism[NCT02467244] | 120 participants (Actual) | Observational | 2017-02-01 | Completed | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
9 reviews available for thyroxine and Arrhythmias, Cardiac
Article | Year |
---|---|
Levothyroxine Treatment and the Risk of Cardiac Arrhythmias - Focus on the Patient Submitted to Thyroid Surgery.
Topics: Arrhythmias, Cardiac; Humans; Hypothyroidism; Postoperative Complications; Thyroid Neoplasms; Thyroi | 2021 |
Clinical practice. Graves' disease.
Topics: Adrenergic beta-Antagonists; Adult; Antithyroid Agents; Arrhythmias, Cardiac; Female; Graves Disease | 2008 |
[Impairment of cardiovascular function in subclinical hypothyroidism].
Topics: Age Factors; Aged; Arrhythmias, Cardiac; Cardiovascular Physiological Phenomena; Diastole; Echocardi | 2003 |
[Role of thyroid hormones in regulation of heart function].
Topics: Arrhythmias, Cardiac; Heart; Heart Conduction System; Heart Failure; Heart Rate; Humans; Hyperthyroi | 2004 |
The brain-heart connection.
Topics: Animals; Arrhythmias, Cardiac; Calcium; Cardiotonic Agents; Catecholamines; Cats; Culture; Death, Su | 2007 |
Amiodarone: the experience of the past decade.
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Dose-Response Relationship, Drug; Drug Interactions; | 1983 |
Hypothyroidism in the elderly.
Topics: Aged; Aging; Anemia; Arrhythmias, Cardiac; Carcinoembryonic Antigen; Creatine Kinase; Diagnosis, Dif | 1984 |
Thyroid hormone and the cardiovascular system.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Heart; Heart Diseases | 2001 |
Atrial natriuretic peptides in pathophysiological diseases.
Topics: Acute Kidney Injury; Animals; Arrhythmias, Cardiac; Ascites; Atrial Natriuretic Factor; Cardiovascul | 2001 |
1 trial available for thyroxine and Arrhythmias, Cardiac
Article | Year |
---|---|
Thyroid hormone levels and protein binding in patients on long-term diphenylhydantoin treatment.
Topics: Adult; Aged; Arrhythmias, Cardiac; Depression, Chemical; Female; Humans; Male; Middle Aged; Phenytoi | 1977 |
75 other studies available for thyroxine and Arrhythmias, Cardiac
Article | Year |
---|---|
Evaluation of Tp-E interval and Tp-E/Qtc ratios in patients with overt hypothyroidism and subclinical hypothyroidism.
Topics: Arrhythmias, Cardiac; Cardiac Conduction System Disease; Electrocardiography; Humans; Hypothyroidism | 2023 |
Role of Subclinical Iatrogenic Hyperthyroidism in the Setting of Heart Disease and Arrhythmic Burden.
Topics: Aged; Arrhythmias, Cardiac; Asymptomatic Diseases; Cardiovascular System; Female; Heart Diseases; Ho | 2020 |
The clinical value of regular thyroid function tests during amiodarone treatment.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Female; Follow-Up Studies; Hu | 2017 |
Relevant researches on chronic viral myocarditis (CVMC) in children, complicated with arrhythmia and thyroid hormone level.
Topics: Adolescent; Arrhythmias, Cardiac; Case-Control Studies; Child; Chronic Disease; Electrocardiography; | 2017 |
Comparison of Therapeutic Triiodothyronine Versus Metoprolol in the Treatment of Myocardial Infarction in Rats.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disease Models, Animal; Echocardiography; Ele | 2018 |
The relationship between the TSH values and the Tpeak - Tend interval duration in hypothyroid patients receiving Levothyroxine treatment.
Topics: Adolescent; Adult; Arrhythmias, Cardiac; Case-Control Studies; Cross-Sectional Studies; Female; Huma | 2019 |
Transient neonatal hypothyroidism following a short course of maternal amiodarone therapy.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Female; Humans; Hypothyroidism; Infant, Ne | 2019 |
Coronary arteriovenous malformation in a dog with a complex arrhythmia and hypothyroidism.
Topics: Animals; Arrhythmias, Cardiac; Arteriovenous Malformations; Atrial Fibrillation; Coronary Vessel Ano | 2019 |
[Effect of subclinical hypothyroidism treatment on selected cardiovascular parameters].
Topics: Adult; Arrhythmias, Cardiac; Echocardiography; Electrocardiography; Electrocardiography, Ambulatory; | 2014 |
Fetuses of Mothers with Thyroid Disease May Be at Higher Risk of Developing Supraventricular Tachycardia.
Topics: Adult; Arrhythmias, Cardiac; Atrial Premature Complexes; Echocardiography; Female; Fetal Diseases; G | 2015 |
Early detection of biochemically occult autonomous thyroid nodules.
Topics: Aged; Arrhythmias, Cardiac; Early Diagnosis; Female; Goiter, Nodular; Humans; Hyperthyroidism; Male; | 2016 |
Thyroid hormone intoxication as a not yet described cause of J-wave syndrome in a pediatric patient.
Topics: Adolescent; Arrhythmias, Cardiac; Dyspnea; Electrocardiography; Humans; Male; Propranolol; Suicide, | 2017 |
[Arrhythmia and vegetative imbalance in hypothyrosis patients].
Topics: Arrhythmias, Cardiac; Autonomic Nervous System Diseases; Comorbidity; Electrocardiography; Female; H | 2008 |
Detrimental effects of thyroid hormone analog DITPA in the mouse heart: increased mortality with in vivo acute myocardial ischemia-reperfusion.
Topics: Animals; Arrhythmias, Cardiac; Blood Pressure; Blotting, Western; Cardiotonic Agents; Data Interpret | 2011 |
Comparison of the symptoms of menopause and symptoms of thyroid disease in Japanese women aged 35-59 years.
Topics: Adult; Arrhythmias, Cardiac; Autoantibodies; Diagnosis, Differential; Female; Flushing; Graves Disea | 2013 |
The effects of early antithyroid therapy for endogenous subclinical hyperthyroidism in clinical and heart abnormalities.
Topics: Adolescent; Adult; Aged; Antithyroid Agents; Arrhythmias, Cardiac; Diastole; Echocardiography; Elect | 2003 |
CARDIOVASCULAR EFFECTS OF THERAPY IN CONGENITAL HYPOTHYROIDISM.
Topics: Arrhythmias, Cardiac; Congenital Hypothyroidism; Drug Therapy; Heart; Heart Rate; Humans; Infant; In | 1965 |
[The specific features of thyrotoxicosis and euthyroid hyperthyroxinemia developed due to the use of cordarone].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Autoantibodies; Blood Flow Velocity; Elect | 2004 |
Effect of sodium channel blocker, pilsicainide hydrochloride, on net inward current of atrial myocytes in thyroid hormone toxicosis rats.
Topics: Action Potentials; Animals; Arrhythmias, Cardiac; Electrocardiography; Heart Atria; Lidocaine; Male; | 2005 |
Amiodarone-induced thyroid dysfunction in cardiac patients from areas with iodine deficiency.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Female; Hu | 2004 |
Prolonged ventricular repolarization measured by corrected QT interval (QTc) in subclinical hyperthyroidism.
Topics: Arrhythmias, Cardiac; Electrocardiography; Female; Heart Ventricles; Humans; Hyperthyroidism; Male; | 2006 |
Amiodarone-induced thyrotoxicosis: left ventricular dysfunction is associated with increased mortality.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Female; Goiter, Nodular; Graves Disease; Humans; Male | 2006 |
[Subclinical hypothyroidism influences ventricular repolarization measured by QTc interval].
Topics: Arrhythmias, Cardiac; Electrocardiography; Heart Conduction System; Heart Ventricles; Humans; Hypoth | 2006 |
Combination of minimally invasive thyroid surgery and local anesthesia associated to iopanoic acid for patients with amiodarone-induced thyrotoxicosis and severe cardiac disorders: a pilot study.
Topics: Aged; Amiodarone; Anesthesia, Local; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Autonomic Nerve B | 2007 |
Long QT interval and ventricular tachycardia of "torsade de pointe" type in hypothyroidism.
Topics: Adrenergic beta-Antagonists; Aged; Arrhythmias, Cardiac; Electrocardiography; Female; Humans; Hypoth | 1983 |
The clinical results of amiodarone in cardiac arrhythmias: optimal dosing.
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Dose-Response Relationship, Drug; Heart Conduction Sy | 1984 |
[Fruste form of hyperthyroidism manifested by auricular arrhythmia. Importance of the assay of the free fraction of thyroxine (FT4) and the role of the TRH test].
Topics: Adult; Aged; Arrhythmias, Cardiac; Female; Heart Atria; Humans; Hyperthyroidism; Male; Middle Aged; | 1984 |
Amiodarone and thyroid function: clinical implications during antiarrhythmic therapy.
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Humans; Hyperthyroidism; Hypothyroidism; Iodides; Mal | 1983 |
Effect of amiodarone on thyroid hormone economy.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Female; Humans; Hyperthyroidism; Hypothy | 1984 |
[Usefulness of the reverse T3 (rT3) determination in patients under chronic treatment with amiodarone].
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Female; Humans; Male; Middle Aged; Thyro | 1984 |
[Radioimmunoassay in the diagnosis of atypical forms of thyrotoxicosis].
Topics: Adult; Arrhythmias, Cardiac; Humans; Hyperthyroidism; Iodine Radioisotopes; Middle Aged; Radioimmuno | 1984 |
Functional significance of chronotropic response during chronic amiodarone therapy.
Topics: Adult; Aged; Amiodarone; Animals; Arrhythmias, Cardiac; Benzofurans; Blood Pressure; Depression, Che | 1984 |
Hyperthyroidism after thyroid suppression.
Topics: Anemia; Arrhythmias, Cardiac; Female; Goiter; Humans; Hypercalcemia; Hyperthyroidism; Iodine Radiois | 1982 |
Hyperthyroxinemia with bradycardia and normal thyrotropin secretion after chronic amiodarone administration.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Heart Rate; Humans; Male; Middle Aged; Thyroid | 1981 |
[Amiodarone and the thyroid gland].
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Female; Humans; Hyperthyroidism; Hypothy | 1981 |
Systemic embolism in thyrotoxicosis without cardiac arrhythmia.
Topics: Adult; Arrhythmias, Cardiac; Cerebrovascular Disorders; Female; Humans; Male; Thromboembolism; Thyro | 1994 |
Control of adrenergic overactivity by beta-blockade improves the quality of life in patients receiving long term suppressive therapy with levothyroxine.
Topics: Adult; Arrhythmias, Cardiac; Bisoprolol; Echocardiography; Electrocardiography; Female; Heart Rate; | 1994 |
Pharmacological actions of "kyushin," a drug containing toad venom (3): Effects on experimentally induced arrhythmia.
Topics: Aconitine; Amphibian Venoms; Animals; Arrhythmias, Cardiac; Autonomic Nervous System; Cats; Digoxin; | 1993 |
Cardiac effects of long term thyrotropin-suppressive therapy with levothyroxine.
Topics: Adult; Arrhythmias, Cardiac; Blood Pressure; Cardiomegaly; Echocardiography; Electrocardiography; El | 1993 |
Acute effects of amiodarone administration on thyroid function in patients with cardiac arrhythmia.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Female; Humans; Kinetics; Male; Middle Aged; Thyroid Disease | 1997 |
Acute effects of intravenous amiodarone on sulphate metabolites of thyroid hormones in arrhythmic patients.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Arrhythmia | 1997 |
Heart hypertrophy induced by levothyroxine aggravates ischemic lesions and reperfusion arrhythmias in rats.
Topics: Action Potentials; Animals; Arrhythmias, Cardiac; Cardiomegaly; Disease Models, Animal; Female; Male | 1997 |
Chronic levothyroxin treatment is associated with ion channel abnormalities in cardiac and neuronal cells.
Topics: Animals; Arrhythmias, Cardiac; Calcium Channels, T-Type; Cardiomegaly; Female; Guinea Pigs; Ion Chan | 1999 |
Successful treatment of amiodarone-induced thyrotoxicosis.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Autoantibodies; Carbimazole; Cohort Studies; Female; Humans; | 2002 |
Iopanoic acid rapidly controls type I amiodarone-induced thyrotoxicosis prior to thyroidectomy.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Drug Resistance; Enzyme Inhibitors; Female; Humans; Iodide P | 2002 |
Amiodarone and the thyroid.
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Child; Humans; Male; Stimulation, Chemical; Thyroid G | 1979 |
Response to thyrotrophin-releasing hormone in atrial dysrhythmias.
Topics: Adult; Aged; Arrhythmias, Cardiac; Atrial Fibrillation; Autoantibodies; Coronary Disease; Female; He | 1978 |
["Autonomous" or "toxic adenoma" of the thyroid. A retrospective evaluation of toxicity (author's transl)].
Topics: Adenoma; Arrhythmias, Cardiac; Humans; Hyperthyroidism; Iodine Radioisotopes; Thyroid Neoplasms; Thy | 1979 |
[Heart function in hyperthyroidism].
Topics: Action Potentials; Age Factors; Animals; Arrhythmias, Cardiac; Atrial Flutter; Cardiac Glycosides; C | 1975 |
Amiodarone treatment in pregnancy for dilatative cardiomyopathy with ventricular malignant extrasystole and normal maternal and neonatal outcome.
Topics: Adult; Amiodarone; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Cardiomyopathy, Dilated; Echo | 1992 |
[Thyroid function in patients during long-term treatment with amiodarone].
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Female; Humans; Male; Middle Aged; Thyroid Diseases; | 1992 |
Hypothyroidism renders protection against lethal ventricular arrhythmias in a conscious canine model of sudden death.
Topics: Animals; Arrhythmias, Cardiac; Death, Sudden, Cardiac; Dogs; Electroencephalography; Electrophysiolo | 1991 |
[Acute antiarrhythmia treatment with amiodarone and blood levels of thyroid hormones].
Topics: Amiodarone; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Female; Humans; Male; Middle Aged; T | 1987 |
The effect of diltiazem, a calcium channel-blocking drug, on cardiac rate and rhythm in hyperthyroid patients.
Topics: Adult; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Diltiazem; Drug Administration Schedule; | 1988 |
[Thyroid hormone prevention of disorders of cardiac contractile function during stress].
Topics: Animals; Arrhythmias, Cardiac; Body Weight; Dose-Response Relationship, Drug; Drug Evaluation, Precl | 1989 |
Amiodarone-induced hypothyroidism. A common complication of prolonged therapy: a report of eight cases.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Female; Humans; Hypothyroidism; Iodides; Iodine | 1985 |
[Ultra-sensitive TSH levels: an aid in the screening for amiodarone-induced thyroid dysfunction].
Topics: Amiodarone; Arrhythmias, Cardiac; Female; Humans; Hyperthyroidism; Male; Middle Aged; Thyrotropin; T | 1986 |
Amiodarone and thyroid status in refractory arrhythmias.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Dose-Response Relationship, Drug; Drug Evaluation; El | 1988 |
Long-term ECG recordings in thyroxine-substituted hypothyroid subjects.
Topics: Adult; Aged; Arrhythmias, Cardiac; Electrocardiography; Female; Humans; Hypothyroidism; Male; Middle | 1987 |
[Effect of short-term administration of phenytoin on blood serum levels of thyroid hormones].
Topics: Adult; Aged; Arrhythmias, Cardiac; Female; Humans; Male; Middle Aged; Phenytoin; Thyroxine; Triiodot | 1987 |
Thyroid dysfunction during chronic amiodarone therapy.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Cholesterol; Female; Humans; Hyperthyroidism; Hypothyroidism | 1987 |
Amiodarone-treated patients with suppressed TSH test are at risk of thyrotoxicosis.
Topics: Adolescent; Adult; Aged; Amiodarone; Angina Pectoris; Arrhythmias, Cardiac; Benzofurans; Female; Hum | 1985 |
Amiodarone. The dilemma of hyperthyroxinaemia and the treatment of thyrotoxicosis.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Carbimazole; Coronary Disease; Humans; Hyperthy | 1985 |
Thyroxine and triiodothyronine kinetics in cardiac patients taking amiodarone.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzofurans; Humans; Kinetics; Middl | 1986 |
Effect of peripheral thyroid hormone metabolism on cardiac arrhythmias.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Humans; Iopanoic Acid; Male; Middle Aged | 1985 |
Effect of long-term amiodarone therapy on thyroid hormone levels and thyroid function.
Topics: Age Factors; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Female; Humans; Hyperthyroidism; H | 1985 |
Amiodarone and thyroid hormone action.
Topics: Adult; Aged; Amiodarone; Animals; Arrhythmias, Cardiac; Benzofurans; Cell Nucleus; Coronary Disease; | 1985 |
[Role of the dynamic changes in serum rT3 levels during long-term administration of amiodarone].
Topics: Adolescent; Adult; Aged; Amiodarone; Animals; Arrhythmias, Cardiac; Benzofurans; Female; Humans; Mal | 1985 |
[The effect of heparin induced increase of free plasma thyroxine on cardiac rhythm after myocardial infarction].
Topics: Aged; Arrhythmias, Cardiac; Electrocardiography; Female; Heparin; Humans; Male; Middle Aged; Monitor | 1985 |
[Plasmapheresis in the treatment of thyrotoxic crisis (author's transl)].
Topics: Arrhythmias, Cardiac; Blood Volume; Evaluation Studies as Topic; Female; Humans; Middle Aged; Plasma | 1974 |
[Preparation for surgical treatment of hyperthyroidism with the aid of propranolol: study of 15 cases].
Topics: Adolescent; Adult; Arrhythmias, Cardiac; Electrocardiography; Female; Humans; Hyperthyroidism; Iodin | 1974 |
Comparison of degree of susceptibility of hyperthyroid and euthyroid animals to cardiac glycoside-induced arrhythmias.
Topics: Animals; Arrhythmias, Cardiac; Blood Pressure; Calcium Chloride; Cardiac Glycosides; Guinea Pigs; He | 1973 |
[Basedow's disease with acute thyrotoxic crisis in a 25-month-old girl].
Topics: Arrhythmias, Cardiac; Carbimazole; Child, Preschool; Dehydration; Diarrhea; Female; Graves Disease; | 1971 |
Spurious heart disease induced by digitalis-containing reducing pills.
Topics: Adult; Arrhythmias, Cardiac; Cathartics; Coronary Disease; Dextroamphetamine; Digitalis Glycosides; | 1968 |
Anti-arrhythmic properties of 1,5-dimorpholino-3-(1-naphthyl)-pentane (DA 1686).
Topics: Aconitum; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzene; Calcium Chloride; Dogs; El | 1968 |